Arcadia Biosciences, Inc. (NASDAQ:RKDA) Short Interest Update

Arcadia Biosciences, Inc. (NASDAQ:RKDA) saw a large decrease in short interest in the month of November. As of November 30th, there was short interest totalling 9,100 shares, a decrease of 53.6% from the November 15th total of 19,600 shares. Based on an average daily volume of 1,140,000 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.7% of the company’s stock are sold short.

Wall Street Analysts Forecast Growth

RKDA has been the subject of several recent research reports. StockNews.com started coverage on Arcadia Biosciences in a research note on Monday. They issued a “sell” rating for the company. HC Wainwright reiterated a “buy” rating and set a $6.00 price target on shares of Arcadia Biosciences in a report on Wednesday, August 21st.

Arcadia Biosciences Stock Performance

Shares of NASDAQ:RKDA traded up $0.12 on Thursday, hitting $6.21. 73,681 shares of the company’s stock were exchanged, compared to its average volume of 325,773. Arcadia Biosciences has a 1-year low of $1.85 and a 1-year high of $10.31. The company has a market capitalization of $8.45 million, a PE ratio of -1.42 and a beta of 1.19. The firm’s 50-day moving average is $3.63 and its 200 day moving average is $3.17.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.